Down-regulation of uncoupling protein-3 and-2 by thiazolidinediones in C2C12 myotubes

被引:16
作者
Cabrero, A [1 ]
Alegret, M [1 ]
Sánchez, RM [1 ]
Adzet, T [1 ]
Laguna, JC [1 ]
Vázquez, M [1 ]
机构
[1] Univ Barcelona, Fac Farm, Dept Farmacol & Quim Terapeut, Unidad Farmacol, E-08028 Barcelona, Spain
关键词
UCP; PPAR; thiazolidinedione; troglitazone; ciglitazone; C2C12;
D O I
10.1016/S0014-5793(00)02125-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uncoupling proteins (UCPs) are mitochondrial membrane proton transporters that uncouple respiration from oxidative phosphorylation by dissipating the proton gradient across the membrane, We studied the direct effect of several peroxisome proliferator-activated receptor (PPAR) ligands on UCP-3 and UCP-2 mRNA expression in C2C12 myotubes for 24 h, In the absence of exogenous fatty acids, treatment of C2C12 cells with a selective PPAR alpha activator (Wy-14,633) or a non-selective PPAR activator (bezafibrate) did not affect the expression of UCP-3 mRNA If, els, whereas UCP-2 expression was slightly increased, In contrast, troglitazone, a thiazolidinenione which selectively activates PPAR gamma, strongly decreased UCP-3 and UCP-2. mRNA levels, Another thiazolidinedione, ciglitazone, had the same effect, but to a lower extent, suggesting that PPAR gamma activation is involved, Further, the presence of 0.5 mM oleic acid strongly increased UCP-3 mRNA levels and troglitazone addition failed to block the effect of this fatty acid. The drop in UCP expression after thiazolidinedione treatment correlated well with a reduction in PPAR alpha mRNA levels produced by this drug, linking the reduction in PPAR alpha mRNA levels with the down-regulation of UCP mRNA in C2C12 myotubes after thiazolidinedione treatment. (C) 2000 Federation of European Biochemical Societies, Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 39 条
[1]   Cloning and characterization of the 5′ flanking region of the human uncoupling protein 3 (UCP3) gene [J].
Acín, A ;
Rodriguez, M ;
Rique, H ;
Canet, E ;
Boutin, JA ;
Galizzi, JP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 258 (02) :278-283
[2]   Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression [J].
Boss, O ;
Samec, S ;
PaoloniGiacobino, A ;
Rossier, C ;
Dulloo, A ;
Seydoux, J ;
Muzzin, P ;
Giacobino, JP .
FEBS LETTERS, 1997, 408 (01) :39-42
[3]   Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans [J].
Bouchard, C ;
Perusse, L ;
Chagnon, YC ;
Warden, C ;
Ricquier, D .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1887-1889
[4]   A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARα agonist with potent lipid-lowering activity [J].
Brown, PJ ;
Winegar, DA ;
Plunket, KD ;
Moore, LB ;
Lewis, MC ;
Wilson, JG ;
Sundseth, SS ;
Koble, CS ;
Wu, ZD ;
Chapman, JM ;
Lehmann, JM ;
Kliewer, SA ;
Willson, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (19) :3785-3788
[5]   Activators of peroxisome proliferator-activated receptor-α induce the expression of the uncoupling protein-3 gene in skeletal muscle -: A potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth [J].
Brun, S ;
Carmona, MC ;
Mampel, T ;
Viñas, O ;
Giralt, M ;
Iglesias, R ;
Villarroya, F .
DIABETES, 1999, 48 (06) :1217-1222
[6]   Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone [J].
Camp, HS ;
Li, O ;
Wise, SC ;
Hong, YH ;
Frankowski, CL ;
Shen, XQ ;
Vanbogelen, R ;
Leff, T .
DIABETES, 2000, 49 (04) :539-547
[8]   Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].
Desvergne, B ;
Wahli, W .
ENDOCRINE REVIEWS, 1999, 20 (05) :649-688
[9]   The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].
Devchand, PR ;
Keller, H ;
Peters, JM ;
Vazquez, M ;
Gonzalez, FJ ;
Wahli, W .
NATURE, 1996, 384 (6604) :39-43
[10]   A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice [J].
Djouadi, F ;
Weinheimer, CJ ;
Saffitz, JE ;
Pitchford, C ;
Bastin, J ;
Gonzalez, FJ ;
Kelly, DP .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (06) :1083-1091